Pub Date : 2025-12-23DOI: 10.1186/s40658-025-00823-7
Kaat Spoormans, Melissa Crabbé, Lara Struelens, Michel Koole
Background: Accurate cellular dosimetry is essential to investigate fundamental mechanisms of targeted radionuclide therapy. The aim of this study was to assess how morphological cellular geometry models influence cellular dosimetry estimates, in comparison to simplified spherical models that do not properly represent an adherent cell geometry.
Methods: Virtual cell models of the CA20948 cell line were generated by confocal microscopy of SSTR2 and DAPI staining and served as input to derive morphological S-values for 177Lu and 161Tb. Absorbed dose-response relationships were established for [177Lu]Lu-DOTA-TATE, [161Tb]Tb-DOTA-TATE, [177Lu]Lu-DOTA-LM3 and [161Tb]Tb-DOTA-LM3 using S-values from both morphological and spherical cell geometries.
Results: Thirty-four cell geometries were modeled and a spherical model with equivalent volume was generated with a radius for the cell and nucleus of 8.6(7) µm and 5.5(6) µm, respectively. Compared to spherical cell models, morphological cell models significantly changed the S-value with an increase of 13% (177Lu) and 22% (161Tb) with the cell membrane as source region and a decrease of 11% (177Lu) and 12% (161Tb) with the cytoplasm as source region. Absorbed dose-response relationships based on morphological cell geometries showed a linear dose-response model for [177Lu]Lu-DOTA-TATE and [161Tb]Tb-DOTA-TATE with α = 0.22[0.18,0.26] Gy-1, and a linear-quadratic dose-response model for [177Lu]Lu-DOTA-LM3 and [161Tb]Tb-DOTA-LM3 with α = 0.000[0.000,0.022] Gy-1 and β = 0.064[0.055,0.072] Gy-2. The assumption of a spherical cell model did not significantly affect the dose-response models, while underestimating the cell dimensions did induce a rescaling of the dose-response models.
Conclusion: These findings validate the use of simplified spherical models for CA20948 cells but highlight the importance of a correct estimation of the cell dimensions.
{"title":"Morphological versus spherical cellular geometry models: impact on dose-response of CA20948 cells to <sup>177</sup>Lu- and <sup>161</sup>Tb-labeled DOTA-TATE and DOTA-LM3.","authors":"Kaat Spoormans, Melissa Crabbé, Lara Struelens, Michel Koole","doi":"10.1186/s40658-025-00823-7","DOIUrl":"10.1186/s40658-025-00823-7","url":null,"abstract":"<p><strong>Background: </strong>Accurate cellular dosimetry is essential to investigate fundamental mechanisms of targeted radionuclide therapy. The aim of this study was to assess how morphological cellular geometry models influence cellular dosimetry estimates, in comparison to simplified spherical models that do not properly represent an adherent cell geometry.</p><p><strong>Methods: </strong>Virtual cell models of the CA20948 cell line were generated by confocal microscopy of SSTR2 and DAPI staining and served as input to derive morphological S-values for <sup>177</sup>Lu and <sup>161</sup>Tb. Absorbed dose-response relationships were established for [<sup>177</sup>Lu]Lu-DOTA-TATE, [<sup>161</sup>Tb]Tb-DOTA-TATE, [<sup>177</sup>Lu]Lu-DOTA-LM3 and [<sup>161</sup>Tb]Tb-DOTA-LM3 using S-values from both morphological and spherical cell geometries.</p><p><strong>Results: </strong>Thirty-four cell geometries were modeled and a spherical model with equivalent volume was generated with a radius for the cell and nucleus of 8.6(7) µm and 5.5(6) µm, respectively. Compared to spherical cell models, morphological cell models significantly changed the S-value with an increase of 13% (<sup>177</sup>Lu) and 22% (<sup>161</sup>Tb) with the cell membrane as source region and a decrease of 11% (<sup>177</sup>Lu) and 12% (<sup>161</sup>Tb) with the cytoplasm as source region. Absorbed dose-response relationships based on morphological cell geometries showed a linear dose-response model for [<sup>177</sup>Lu]Lu-DOTA-TATE and [<sup>161</sup>Tb]Tb-DOTA-TATE with α = 0.22[0.18,0.26] Gy-1, and a linear-quadratic dose-response model for [<sup>177</sup>Lu]Lu-DOTA-LM3 and [<sup>161</sup>Tb]Tb-DOTA-LM3 with α = 0.000[0.000,0.022] Gy-1 and β = 0.064[0.055,0.072] Gy-2. The assumption of a spherical cell model did not significantly affect the dose-response models, while underestimating the cell dimensions did induce a rescaling of the dose-response models.</p><p><strong>Conclusion: </strong>These findings validate the use of simplified spherical models for CA20948 cells but highlight the importance of a correct estimation of the cell dimensions.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"8"},"PeriodicalIF":3.2,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12847496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-22DOI: 10.1186/s40658-025-00812-w
Remco J Poelarends, Jorn A van Dalen, Brian N Vendel, Henk Stevens, Joris D van Dijk
Background: Interpreting [18F]PSMA-1007 PET/CT scans can be challenging due to the occurrence of unspecific uptake in lymph nodes and bones. Machine learning has proven its suitability to use features to model complex relations leading to accurate diagnosis. We aimed to investigate the impact of contextual information on machine learning performance in identifying lymph node and bone metastases in prostate cancer patients using [18F]PSMA-1007 PET. A Random Forest Classifier (RFC) and Extreme Gradient Boosting (XGBoost) were trained across two feature sets to classify hotspots into malignant or non-malignant. The first set incorporated hotspot-specific features, such as SUVmax, anatomic location and tissue type of the location (lymph node/bone). The second set was the first set combined with context-level features, such as SUVmax of nearby hotspots and the number of hotspots.
Results: We retrospectively included 103 patients who underwent clinically indicated [18F]PSMA-1007 PET/CT, in whom hotspots were observed in lymph nodes (n = 256) and bone structures (n = 267). The context-enhanced model outperformed the hotspot-specific model in Area Under The Curve (AUC) and Youden Index for both RFC and XGBoost. The context-enhanced RFC performed superior in AUC for bone (0.92, p < 0.001) and lymph node hotspots (0.95, p < 0.001). The performance increase after adding contextual information was stronger for bone hotspots compared to lymph node hotspots in terms of AUC (0.06 vs. 0.03, p < 0.001) and Youden Index (0.15 vs. 0.07, p < 0.001).
Conclusion: We successfully developed models to accurately identify lymph node and bone metastases. We underscored the potential of leveraging contextual information in machine learning methods to improve the identification of lymph node and bone metastases.
背景:解释[18F]PSMA-1007 PET/CT扫描可能具有挑战性,因为在淋巴结和骨骼中出现非特异性摄取。机器学习已经证明了它使用特征来建模复杂关系从而进行准确诊断的适用性。我们的目的是研究上下文信息对机器学习性能的影响,使用[18F]PSMA-1007 PET识别前列腺癌患者的淋巴结和骨转移。随机森林分类器(RFC)和极端梯度增强(XGBoost)在两个特征集上进行训练,将热点分类为恶性或非恶性。第一组纳入了热点特异性特征,如SUVmax,解剖位置和位置的组织类型(淋巴结/骨)。第二组是第一组结合上下文级别的特征,如附近热点的SUVmax和热点的数量。结果:我们回顾性纳入103例经临床指征[18F]PSMA-1007 PET/CT检查的患者,其中淋巴结(n = 256)和骨结构(n = 267)出现热点。对于RFC和XGBoost,上下文增强模型在曲线下面积(Area Under The Curve, AUC)和约登指数(Youden Index)方面优于热点特定模型。上下文增强的RFC在骨AUC方面表现更好(0.92,p)。结论:我们成功开发了准确识别淋巴结和骨转移的模型。我们强调了在机器学习方法中利用上下文信息来提高淋巴结和骨转移识别的潜力。
{"title":"Context-level machine learning to improve the identification of lymph node and bone metastases in prostate cancer patients using [<sup>18</sup>F]PSMA-1007 PET.","authors":"Remco J Poelarends, Jorn A van Dalen, Brian N Vendel, Henk Stevens, Joris D van Dijk","doi":"10.1186/s40658-025-00812-w","DOIUrl":"10.1186/s40658-025-00812-w","url":null,"abstract":"<p><strong>Background: </strong>Interpreting [<sup>18</sup>F]PSMA-1007 PET/CT scans can be challenging due to the occurrence of unspecific uptake in lymph nodes and bones. Machine learning has proven its suitability to use features to model complex relations leading to accurate diagnosis. We aimed to investigate the impact of contextual information on machine learning performance in identifying lymph node and bone metastases in prostate cancer patients using [<sup>18</sup>F]PSMA-1007 PET. A Random Forest Classifier (RFC) and Extreme Gradient Boosting (XGBoost) were trained across two feature sets to classify hotspots into malignant or non-malignant. The first set incorporated hotspot-specific features, such as SUVmax, anatomic location and tissue type of the location (lymph node/bone). The second set was the first set combined with context-level features, such as SUVmax of nearby hotspots and the number of hotspots.</p><p><strong>Results: </strong>We retrospectively included 103 patients who underwent clinically indicated [<sup>18</sup>F]PSMA-1007 PET/CT, in whom hotspots were observed in lymph nodes (n = 256) and bone structures (n = 267). The context-enhanced model outperformed the hotspot-specific model in Area Under The Curve (AUC) and Youden Index for both RFC and XGBoost. The context-enhanced RFC performed superior in AUC for bone (0.92, p < 0.001) and lymph node hotspots (0.95, p < 0.001). The performance increase after adding contextual information was stronger for bone hotspots compared to lymph node hotspots in terms of AUC (0.06 vs. 0.03, p < 0.001) and Youden Index (0.15 vs. 0.07, p < 0.001).</p><p><strong>Conclusion: </strong>We successfully developed models to accurately identify lymph node and bone metastases. We underscored the potential of leveraging contextual information in machine learning methods to improve the identification of lymph node and bone metastases.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":"12 1","pages":"101"},"PeriodicalIF":3.2,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12722587/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-17DOI: 10.1186/s40658-025-00822-8
Minseok Suh, Keon Min Kim, Jin Woo Choi, Jae Sung Lee, Jin Chul Paeng, Hyo-Cheol Kim
Purpose: We applied a voxel-based personalized dosimetry method using multiple voxel S-values (VSVs) to assess the intratumoral dose distribution in hepatocellular carcinoma (HCC) patients treated with trans-arterial radioembolization (TARE) using glass microspheres. This study aimed to evaluate the predictive value of dose metrics for treatment response and local progression-free survival (L-PFS).
Methods: Ninety patients with HCC who underwent TARE between November 2015 and December 2019 were retrospectively analyzed. Post-treatment 90Y-microsphere PET/CT images were used to generate voxel-wise absorbed dose maps via convolution with CT-derived multiple VSV kernels. Tumor volumes were manually delineated on contrast-enhanced CT co-registered with dose map. Dose-volume histogram (DVH) parameters, including V-V205 (tumor volume receiving < 205 Gy) and D70, were calculated. Dose heterogeneity was assessed using the coefficient of variation (CoV) of voxel doses. The performance of dose parameters for predicting complete response (CR) and L-PFS was evaluated using logistic and Cox regression analyses.
Results: Among 90 patients, 57 (63.3%) achieved CR. PET average dose, D70, V-V205, and CoV significantly differed according to treatment response. ROC analysis showed good predictive performance for CR with D70 (AUC 0.908), V-V205 (0.903), PET average dose (0.876), and CoV (0.870). In multivariate logistic regression, only small V-V205 (< 22.8 mL; OR 12.50, P = 0.002) remained an independent predictor of CR. For L-PFS, multivariate Cox analysis identified V-V205 < 22.8 mL (HR 0.07, P = 0.013) and CR (HR 0.29, P = 0.034) as independent prognostic factors.
Conclusion: Voxel-based dosimetry using multiple VSV kernels enables quantitative assessment of intratumoral dose distribution in HCC patients treated with TARE. Among voxel-level parameters, D70, V-V205, and CoV showed good performance in predicting CR, and V-V205 was the only independent predictor for both treatment response and L-PFS. These findings support the added prognostic value of voxel-based dose metrics beyond average tumor absorbed dose.
{"title":"Voxel-based dosimetry for predicting treatment response to transarterial radioembolization in hepatocellular carcinoma: significance of intratumoral dose distribution.","authors":"Minseok Suh, Keon Min Kim, Jin Woo Choi, Jae Sung Lee, Jin Chul Paeng, Hyo-Cheol Kim","doi":"10.1186/s40658-025-00822-8","DOIUrl":"10.1186/s40658-025-00822-8","url":null,"abstract":"<p><strong>Purpose: </strong>We applied a voxel-based personalized dosimetry method using multiple voxel S-values (VSVs) to assess the intratumoral dose distribution in hepatocellular carcinoma (HCC) patients treated with trans-arterial radioembolization (TARE) using glass microspheres. This study aimed to evaluate the predictive value of dose metrics for treatment response and local progression-free survival (L-PFS).</p><p><strong>Methods: </strong>Ninety patients with HCC who underwent TARE between November 2015 and December 2019 were retrospectively analyzed. Post-treatment <sup>90</sup>Y-microsphere PET/CT images were used to generate voxel-wise absorbed dose maps via convolution with CT-derived multiple VSV kernels. Tumor volumes were manually delineated on contrast-enhanced CT co-registered with dose map. Dose-volume histogram (DVH) parameters, including V-V<sub>205</sub> (tumor volume receiving < 205 Gy) and D70, were calculated. Dose heterogeneity was assessed using the coefficient of variation (CoV) of voxel doses. The performance of dose parameters for predicting complete response (CR) and L-PFS was evaluated using logistic and Cox regression analyses.</p><p><strong>Results: </strong>Among 90 patients, 57 (63.3%) achieved CR. PET average dose, D70, V-V<sub>205</sub>, and CoV significantly differed according to treatment response. ROC analysis showed good predictive performance for CR with D70 (AUC 0.908), V-V<sub>205</sub> (0.903), PET average dose (0.876), and CoV (0.870). In multivariate logistic regression, only small V-V<sub>205</sub> (< 22.8 mL; OR 12.50, P = 0.002) remained an independent predictor of CR. For L-PFS, multivariate Cox analysis identified V-V<sub>205</sub> < 22.8 mL (HR 0.07, P = 0.013) and CR (HR 0.29, P = 0.034) as independent prognostic factors.</p><p><strong>Conclusion: </strong>Voxel-based dosimetry using multiple VSV kernels enables quantitative assessment of intratumoral dose distribution in HCC patients treated with TARE. Among voxel-level parameters, D70, V-V<sub>205</sub>, and CoV showed good performance in predicting CR, and V-V<sub>205</sub> was the only independent predictor for both treatment response and L-PFS. These findings support the added prognostic value of voxel-based dose metrics beyond average tumor absorbed dose.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"6"},"PeriodicalIF":3.2,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145767507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16DOI: 10.1186/s40658-025-00814-8
Quentin Maronnier, Thibaut Cassou-Mounat, Erwan Gabiache, Adrien Latgé, Marie Terroir, Lavinia Vija, Kuan-Hao Su, Olivier Caselles, Frédéric Courbon
Background: We evaluate the Omni Legend 32 cm (OMNI6R), a digital-BGO PET/CT using the deep learning (DL) based algorithm, Precision Deep Learning (PDL), emulating time-of-flight (TOF) enhancement and compare its performance to the TOF-equipped Discovery-MI 25 cm (DMI5R) in terms of detection sensitivity, quantification, and overall image quality.
Methods: Thirty patients were administered with an average single dose of 2 MBq/kg [18F]-FDG and were scanned consecutively on DMI5R first and on OMNI6R afterwards. Total scan duration on DMI5R and OMNI6R were 10 and 6 min, respectively. OMNI6R data were reconstructed using Bayesian Penalized Likelihood (BPL) algorithm with a beta of 650 and PDL-High setting. A total of 150 inserted synthetic lesions (ISL), ranging in size from 6 to 10 mm and exhibiting contrast levels between 3 and 15 relative to their initial background activity, were distributed across the cohort. Three readers blindly assessed detection sensitivity and quantification of these lesions. We tested a non-inferiority hypothesis based on the ISL true positive rate (TPR) and compared calculated recovery coefficients (RC) using SUVmean and SUVmax metrics of the detected ISL. Additionally, image quality, sharpness, conspicuity, noise characteristics, and diagnostic confidence were assessed as clinical quality indicators with a 5-point Likert scale on clinical images without ISL, using same beta as DMI5R and different PDL settings (None, High, Medium, Low).
Results: TPR were 84.67% (95% CI 80.04-89.29%) and 84.44% (95% CI 77.76-91.13%) respectively for DMI5R and OMNI6R-PDL-High, and demonstrated non-inferiority. OMNI6R-PDL-High yielded higher RC without overestimation for all ISL sizes. Remarkably, these findings were observed despite a 9% activity decay in ISL and a 40% reduction in whole-body acquisition time. All PDL settings led to increased average median scores across clinical quality metrics, surpassing the DMI5R in most cases.
Conclusions: OMNI6R using PDL-High demonstrated non-inferior diagnostic performance compared to DMI5R, as evidenced by ISL detection sensitivity and quantitation. Importantly, the use of OMNI-PDL-High did not increase the risk of false-negative findings, despite reductions in activity and acquisition time. OMNI6R using PDL enhances overall image quality while improving clinical workflow and patient comfort. These results support DL-based enhancement algorithms as effective solutions for non-TOF PET imaging. Trial registration number and date of registration: NCT05154877, December 13th 2021.
背景:我们使用基于深度学习(DL)的算法,精确深度学习(PDL),模拟飞行时间(TOF)增强,评估了Omni Legend 32 cm (OMNI6R),这是一种数字bgo PET/CT,并将其性能与配备TOF的Discovery-MI 25 cm (DMI5R)在检测灵敏度,量化和整体图像质量方面进行了比较。方法:30例患者给予平均单次剂量2 MBq/kg [18F]-FDG,先进行DMI5R扫描,后进行OMNI6R扫描。DMI5R和OMNI6R的总扫描时间分别为10分钟和6分钟。采用贝叶斯惩罚似然(BPL)算法重构OMNI6R数据,beta值为650,设置PDL-High。总共150个插入性合成病变(ISL)分布在整个队列中,大小从6到10毫米不等,相对于其初始背景活动,对比度水平在3到15之间。三位读者盲目地评估了这些病变的检测灵敏度和定量。我们基于ISL真阳性率(TPR)检验了一个非劣效性假设,并使用检测到的ISL的SUVmean和SUVmax指标比较了计算的恢复系数(RC)。此外,使用与DMI5R相同的beta值和不同的PDL设置(无、高、中、低),以5点李克特量表评估无ISL临床图像的图像质量、清晰度、显著性、噪声特征和诊断置信度作为临床质量指标。结果:DMI5R和OMNI6R-PDL-High的TPR分别为84.67% (95% CI 80.04 ~ 89.29%)和84.44% (95% CI 77.76 ~ 91.13%),无劣效性。OMNI6R-PDL-High对所有ISL尺寸均产生更高的RC而不会高估。值得注意的是,这些发现是在ISL活动下降9%和全身获取时间减少40%的情况下观察到的。所有PDL设置导致临床质量指标的平均中位数得分增加,在大多数情况下超过DMI5R。结论:使用PDL-High的OMNI6R的诊断性能优于DMI5R, ISL检测灵敏度和定量证明了这一点。重要的是,使用OMNI-PDL-High并没有增加假阴性结果的风险,尽管活动和获取时间减少了。使用PDL的OMNI6R增强了整体图像质量,同时改善了临床工作流程和患者舒适度。这些结果支持基于dl的增强算法作为非tof PET成像的有效解决方案。试验注册号及注册日期:NCT05154877, 2021年12月13日。
{"title":"Deep learning-enhanced digital-BGO versus TOF PET/CT: comparative assessment of detection, quantitation, and overall image quality.","authors":"Quentin Maronnier, Thibaut Cassou-Mounat, Erwan Gabiache, Adrien Latgé, Marie Terroir, Lavinia Vija, Kuan-Hao Su, Olivier Caselles, Frédéric Courbon","doi":"10.1186/s40658-025-00814-8","DOIUrl":"10.1186/s40658-025-00814-8","url":null,"abstract":"<p><strong>Background: </strong>We evaluate the Omni Legend 32 cm (OMNI6R), a digital-BGO PET/CT using the deep learning (DL) based algorithm, Precision Deep Learning (PDL), emulating time-of-flight (TOF) enhancement and compare its performance to the TOF-equipped Discovery-MI 25 cm (DMI5R) in terms of detection sensitivity, quantification, and overall image quality.</p><p><strong>Methods: </strong>Thirty patients were administered with an average single dose of 2 MBq/kg [<sup>18</sup>F]-FDG and were scanned consecutively on DMI5R first and on OMNI6R afterwards. Total scan duration on DMI5R and OMNI6R were 10 and 6 min, respectively. OMNI6R data were reconstructed using Bayesian Penalized Likelihood (BPL) algorithm with a beta of 650 and PDL-High setting. A total of 150 inserted synthetic lesions (ISL), ranging in size from 6 to 10 mm and exhibiting contrast levels between 3 and 15 relative to their initial background activity, were distributed across the cohort. Three readers blindly assessed detection sensitivity and quantification of these lesions. We tested a non-inferiority hypothesis based on the ISL true positive rate (TPR) and compared calculated recovery coefficients (RC) using SUVmean and SUVmax metrics of the detected ISL. Additionally, image quality, sharpness, conspicuity, noise characteristics, and diagnostic confidence were assessed as clinical quality indicators with a 5-point Likert scale on clinical images without ISL, using same beta as DMI5R and different PDL settings (None, High, Medium, Low).</p><p><strong>Results: </strong>TPR were 84.67% (95% CI 80.04-89.29%) and 84.44% (95% CI 77.76-91.13%) respectively for DMI5R and OMNI6R-PDL-High, and demonstrated non-inferiority. OMNI6R-PDL-High yielded higher RC without overestimation for all ISL sizes. Remarkably, these findings were observed despite a 9% activity decay in ISL and a 40% reduction in whole-body acquisition time. All PDL settings led to increased average median scores across clinical quality metrics, surpassing the DMI5R in most cases.</p><p><strong>Conclusions: </strong>OMNI6R using PDL-High demonstrated non-inferior diagnostic performance compared to DMI5R, as evidenced by ISL detection sensitivity and quantitation. Importantly, the use of OMNI-PDL-High did not increase the risk of false-negative findings, despite reductions in activity and acquisition time. OMNI6R using PDL enhances overall image quality while improving clinical workflow and patient comfort. These results support DL-based enhancement algorithms as effective solutions for non-TOF PET imaging. Trial registration number and date of registration: NCT05154877, December 13th 2021.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"4"},"PeriodicalIF":3.2,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Head motion during brain positron emission tomography (PET) degrades image quality and quantitative accuracy. Therefore, a data-driven motion correction (MC) method utilizing ultrafast list-mode reconstruction technology has been proposed and shown to considerably improve image quality. However, reproducing accurate actual motions and motion-free images using clinical data alone remains challenging. This study aimed to quantitatively evaluate data-driven MC using a brain phantom for known tracer distributions and a custom-made motion generator system for variable known motions.
Methods: Hoffman 3D brain phantom was filled with 20 and 3 MBq of [18F]fluoro-2-deoxy-D-glucose (FDG) to simulate high- and low-radioactivity conditions corresponding to brain FDG PET and amyloid PET acquisitions, respectively. Two separate phantom measurements were performed accordingly. Motion simulation was conducted using a custom-designed motion generator, incorporating 15° and 30° rotations about the z-axis, 3° and 6° rotations about the x-axis, and 5 mm and 10 mm translations along the z-axis in the PET image coordinates. The data-driven MC was applied with frame durations of 1, 2, 5, 10, and 20 s for motion estimation. The estimated motions were compared with the motions measured using an external optical tracker system. %contrast and gray matter coefficient of variation (CV%) were calculated from the motion-corrected PET images.
Results: The motion generator system successfully reproduced the designed motions. Motion estimation remained stable under high-radioactivity condition but showed reduced stability under low-radioactivity condition, particularly with shorter frame durations. Under both conditions, longer frame durations led to underestimation of continuous motion. The data-driven MC improved %contrast and gray matter CV% across all conditions, with shorter frame durations providing better correction for quick or continuous motions. However, shorter frame durations increased statistical noise, especially under low-radioactivity condition.
Conclusion: The data-driven MC effectively improved the quality of motion-affected PET images under both high- and low-radioactivity conditions, indicating its broad applicability. However, correction accuracy deteriorated under the lower-radioactivity condition.
{"title":"Quantitative validation of data-driven motion correction for brain PET using phantom with motion generator system.","authors":"Yuto Kamitaka, Muneyuki Sakata, Keiichi Oda, Akie Katsuki, Hirofumi Kawakami, Kei Wagatsuma, Masato Kobayashi, Kenji Ishii","doi":"10.1186/s40658-025-00820-w","DOIUrl":"10.1186/s40658-025-00820-w","url":null,"abstract":"<p><strong>Background: </strong>Head motion during brain positron emission tomography (PET) degrades image quality and quantitative accuracy. Therefore, a data-driven motion correction (MC) method utilizing ultrafast list-mode reconstruction technology has been proposed and shown to considerably improve image quality. However, reproducing accurate actual motions and motion-free images using clinical data alone remains challenging. This study aimed to quantitatively evaluate data-driven MC using a brain phantom for known tracer distributions and a custom-made motion generator system for variable known motions.</p><p><strong>Methods: </strong>Hoffman 3D brain phantom was filled with 20 and 3 MBq of [<sup>18</sup>F]fluoro-2-deoxy-D-glucose (FDG) to simulate high- and low-radioactivity conditions corresponding to brain FDG PET and amyloid PET acquisitions, respectively. Two separate phantom measurements were performed accordingly. Motion simulation was conducted using a custom-designed motion generator, incorporating 15° and 30° rotations about the z-axis, 3° and 6° rotations about the x-axis, and 5 mm and 10 mm translations along the z-axis in the PET image coordinates. The data-driven MC was applied with frame durations of 1, 2, 5, 10, and 20 s for motion estimation. The estimated motions were compared with the motions measured using an external optical tracker system. %contrast and gray matter coefficient of variation (CV%) were calculated from the motion-corrected PET images.</p><p><strong>Results: </strong>The motion generator system successfully reproduced the designed motions. Motion estimation remained stable under high-radioactivity condition but showed reduced stability under low-radioactivity condition, particularly with shorter frame durations. Under both conditions, longer frame durations led to underestimation of continuous motion. The data-driven MC improved %contrast and gray matter CV% across all conditions, with shorter frame durations providing better correction for quick or continuous motions. However, shorter frame durations increased statistical noise, especially under low-radioactivity condition.</p><p><strong>Conclusion: </strong>The data-driven MC effectively improved the quality of motion-affected PET images under both high- and low-radioactivity conditions, indicating its broad applicability. However, correction accuracy deteriorated under the lower-radioactivity condition.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"5"},"PeriodicalIF":3.2,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12824033/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145762667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: ACTIVE 7 MAX is a compact benchtop preclinical PET scanner dedicated to high sensitivity and high-resolution imaging of small animals. This study evaluated the performance of the ACTIVE 7 MAX system using the National Electrical Manufacturers Association NU 4-2008 standard protocol.
Methods: The scanner consists of four rings, each containing 14 detector modules. Each detector module is made up of a 16 × 16 array of lutetium yttrium orthosilicate (LYSO) scintillation crystals, with each crystal measuring 1.47 × 1.47 × 10.0 mm3. The crystal array was coupled to a novel 6 × 6 epitaxial-quenching-resistor silicon photomultiplier (EQR SiPM) array. Flood images and energy resolution were obtained by irradiating each detector module with a 18F source.
Results: The average energy resolution for the 56 detector modules in the system was found to be 11.46% in Full Width at Half Maximum (FWHM). The filtered back-projection (FBP) image spatial resolution of a point source varied from 1.57 to 1.81 mm in the radial direction and from 1.58 to 1.71 mm in the tangential direction within the radius of 25 mm. For the Derenzo phantom imaging, the hot rod with a diameter of 1.25 mm was identified. With an energy window of 350-650 keV, the sensitivity at the center of the scanner was 4.18%. The peak noise equivalent count rate (NECR) of 103 kcps was achieved at 22 MBq, and the scatter fraction (SF) is 12%. The reconstructed images of the NEMA image quality phantom show a uniformity of 5.0%, and recovery coefficients for rods with diameters of 1 mm and 5 mm ranging from 0.14 to 0.93. The spillover rates for air-filled and water-filled cold regions were 0.08 and 0.03, respectively.
Conclusion: This study evaluated the performance of the ACTIVE 7 MAX preclinical PET system. The results demonstrated excellent imaging performance for molecular imaging in biomedical studies.
{"title":"Performance evaluation of the ACTIVE 7 MAX benchtop preclinical PET scanner in accordance with the NEMA NU 4-2008 standard.","authors":"Haihao Wang, Kexin Wang, Ziquan Yuan, Chenxi Li, Runze Liao, Yucun Hou, Jianlang Hua, Yi Tang, Qing Ruan, Dejun Han, Jianyong Jiang","doi":"10.1186/s40658-025-00813-9","DOIUrl":"10.1186/s40658-025-00813-9","url":null,"abstract":"<p><strong>Introduction: </strong>ACTIVE 7 MAX is a compact benchtop preclinical PET scanner dedicated to high sensitivity and high-resolution imaging of small animals. This study evaluated the performance of the ACTIVE 7 MAX system using the National Electrical Manufacturers Association NU 4-2008 standard protocol.</p><p><strong>Methods: </strong>The scanner consists of four rings, each containing 14 detector modules. Each detector module is made up of a 16 × 16 array of lutetium yttrium orthosilicate (LYSO) scintillation crystals, with each crystal measuring 1.47 × 1.47 × 10.0 mm<sup>3</sup>. The crystal array was coupled to a novel 6 × 6 epitaxial-quenching-resistor silicon photomultiplier (EQR SiPM) array. Flood images and energy resolution were obtained by irradiating each detector module with a <sup>18</sup>F source.</p><p><strong>Results: </strong>The average energy resolution for the 56 detector modules in the system was found to be 11.46% in Full Width at Half Maximum (FWHM). The filtered back-projection (FBP) image spatial resolution of a point source varied from 1.57 to 1.81 mm in the radial direction and from 1.58 to 1.71 mm in the tangential direction within the radius of 25 mm. For the Derenzo phantom imaging, the hot rod with a diameter of 1.25 mm was identified. With an energy window of 350-650 keV, the sensitivity at the center of the scanner was 4.18%. The peak noise equivalent count rate (NECR) of 103 kcps was achieved at 22 MBq, and the scatter fraction (SF) is 12%. The reconstructed images of the NEMA image quality phantom show a uniformity of 5.0%, and recovery coefficients for rods with diameters of 1 mm and 5 mm ranging from 0.14 to 0.93. The spillover rates for air-filled and water-filled cold regions were 0.08 and 0.03, respectively.</p><p><strong>Conclusion: </strong>This study evaluated the performance of the ACTIVE 7 MAX preclinical PET system. The results demonstrated excellent imaging performance for molecular imaging in biomedical studies.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"3"},"PeriodicalIF":3.2,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145755606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1186/s40658-025-00817-5
Dániel Réti, Carlos-Alcaide Corral, Islay Cranston, Victoria J M Reid, Kerry M O'Rourke, Timaeus E F Morgan, Axel Montagne, Maurits A Jansen, Valeria K Burianova, Andrew Sutherland, Péter Major, Kálmán Nagy, Gergő Bagaméry, Adriana A S Tavares
Purpose: Before utilising preclinical Position Emission Tomography (PET) systems for biological studies, evaluating their performance is important to better qualify the scanner's applications. This study aims to assess the performance of the new extended field of view (FOV) nanoScan® PET/CT P123S system, developed for rodent total-body PET applications.
Methods: Scanner resolution, noise equivalent count rate (NECR), sensitivity and image quality were evaluated following NEMA NU-4 2008 protocols. Furthermore, a Derenzo phantom and linearity measurements were conducted. In vivo studies were subsequently carried out to evaluate system performance in biological applications.
Results: The scanner spatial resolution according to the NEMA protocol was 1.4 mm using FBP reconstruction, while with iterative reconstruction it was under 0.7 mm. The NECR peak using a 250‒750 keV energy window was 1805.0 kcps at 93.7 MBq and 880.7 kcps at 88.4 MBq for the mouse-sized and rat-sized phantom respectively. The absolute sensitivity was 10.5%. The standard deviation of the uniform area of the image quality phantom was 1.8%, while the recovery coefficients varied between 0.23 and 1.00. The spill-over ratios were 0.04, and 0.04 in the water and air-filled chambers respectively. Quantitative bias was < 4% with a linear response up to 105 MBq. Total-body rat images were successfully acquired using the new system.
Conclusion: The new extended FOV PET system has improved sensitivity and count rate performance compared with previous systems. Its spatial resolution and quantitative accuracy are well-suited for preclinical PET applications. The extended FOV enables total-body imaging of both mice and rats.
{"title":"Performance evaluation of the nanoScan<sup>®</sup> P123S total-body PET.","authors":"Dániel Réti, Carlos-Alcaide Corral, Islay Cranston, Victoria J M Reid, Kerry M O'Rourke, Timaeus E F Morgan, Axel Montagne, Maurits A Jansen, Valeria K Burianova, Andrew Sutherland, Péter Major, Kálmán Nagy, Gergő Bagaméry, Adriana A S Tavares","doi":"10.1186/s40658-025-00817-5","DOIUrl":"10.1186/s40658-025-00817-5","url":null,"abstract":"<p><strong>Purpose: </strong>Before utilising preclinical Position Emission Tomography (PET) systems for biological studies, evaluating their performance is important to better qualify the scanner's applications. This study aims to assess the performance of the new extended field of view (FOV) nanoScan® PET/CT P123S system, developed for rodent total-body PET applications.</p><p><strong>Methods: </strong>Scanner resolution, noise equivalent count rate (NECR), sensitivity and image quality were evaluated following NEMA NU-4 2008 protocols. Furthermore, a Derenzo phantom and linearity measurements were conducted. In vivo studies were subsequently carried out to evaluate system performance in biological applications.</p><p><strong>Results: </strong>The scanner spatial resolution according to the NEMA protocol was 1.4 mm using FBP reconstruction, while with iterative reconstruction it was under 0.7 mm. The NECR peak using a 250‒750 keV energy window was 1805.0 kcps at 93.7 MBq and 880.7 kcps at 88.4 MBq for the mouse-sized and rat-sized phantom respectively. The absolute sensitivity was 10.5%. The standard deviation of the uniform area of the image quality phantom was 1.8%, while the recovery coefficients varied between 0.23 and 1.00. The spill-over ratios were 0.04, and 0.04 in the water and air-filled chambers respectively. Quantitative bias was < 4% with a linear response up to 105 MBq. Total-body rat images were successfully acquired using the new system.</p><p><strong>Conclusion: </strong>The new extended FOV PET system has improved sensitivity and count rate performance compared with previous systems. Its spatial resolution and quantitative accuracy are well-suited for preclinical PET applications. The extended FOV enables total-body imaging of both mice and rats.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"2"},"PeriodicalIF":3.2,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12779859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145699860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: This study aims to develop and validate a dual-time-window (DTW) Patlak plot method that eliminates the need for invasive blood sampling and reduces scan duration. We seek to improve the accuracy of the net influx constant ([Formula: see text]) estimation, addressing the inaccuracies inherent in traditional DTW and single-time-window methods, which often introduce bias and hinder comparability across different cohorts.
Method: We developed an unsupervised, multi-branch neural network (NN) to assist in estimating missing data intervals within the DTW protocol, thereby facilitating accurate Patlak analysis. The model fits the mapping from time to the time-activity curve (TAC), generating multiple pseudo input functions (IFs). A correlation coefficient is then computed between each pseudo IF and the voxel-level measured data, extracting statistical information guided by the kinetic process. These correlation scores were used to construct a weighted statistic, serving as the final IF (NNIF). Our approach was validated using both simulation and clinical data, including [Formula: see text]-FDG PET scans from 67 lung cancer subjects. Additionally, we compared the performance of our method with other simplified quantification techniques to demonstrate its efficacy in achieving high-quality parametric imaging and reliable quantitative analysis within abbreviated scanning protocols.
Result: Our proposed method achieved high accuracy in the estimation of IF, with a maximum mean absolute deviation (MAD) of 0.04 in a real patient study. The regressed [Formula: see text] derived from different DTW scan protocols exhibited good consistency. In simulation studies , the best relative absolute error (RAE) was 0.0302. In real patient study, the optimal average peak signal-to-noise ratio (PSNR) of parametric imaging reached 97.40 dB, while the best average R-squared ([Formula: see text]) in ROI-based quantitative analysis reached 0.991.
Conclusions: We demonstrate the feasibility of using a weighted statistic, constructed from a multi-branch neural network, to accurately estimate the complete IF. This approach enables the generation of high-quality parametric images with shortened scan protocols, effectively reducing scanning time while ensuring accurate Patlak analysis.
{"title":"Neural network-aided unsupervised input function estimation for dual-time-window PET Patlak analysis.","authors":"Wenrui Shao, Yarong Zhang, Fen Du, Fangxiao Cheng, Yixin Chen, Xiangxi Meng, Ying Liang, Zhaoheng Xie","doi":"10.1186/s40658-025-00804-w","DOIUrl":"10.1186/s40658-025-00804-w","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to develop and validate a dual-time-window (DTW) Patlak plot method that eliminates the need for invasive blood sampling and reduces scan duration. We seek to improve the accuracy of the net influx constant ([Formula: see text]) estimation, addressing the inaccuracies inherent in traditional DTW and single-time-window methods, which often introduce bias and hinder comparability across different cohorts.</p><p><strong>Method: </strong>We developed an unsupervised, multi-branch neural network (NN) to assist in estimating missing data intervals within the DTW protocol, thereby facilitating accurate Patlak analysis. The model fits the mapping from time to the time-activity curve (TAC), generating multiple pseudo input functions (IFs). A correlation coefficient is then computed between each pseudo IF and the voxel-level measured data, extracting statistical information guided by the kinetic process. These correlation scores were used to construct a weighted statistic, serving as the final IF (NNIF). Our approach was validated using both simulation and clinical data, including [Formula: see text]-FDG PET scans from 67 lung cancer subjects. Additionally, we compared the performance of our method with other simplified quantification techniques to demonstrate its efficacy in achieving high-quality parametric imaging and reliable quantitative analysis within abbreviated scanning protocols.</p><p><strong>Result: </strong>Our proposed method achieved high accuracy in the estimation of IF, with a maximum mean absolute deviation (MAD) of 0.04 in a real patient study. The regressed [Formula: see text] derived from different DTW scan protocols exhibited good consistency. In simulation studies , the best relative absolute error (RAE) was 0.0302. In real patient study, the optimal average peak signal-to-noise ratio (PSNR) of parametric imaging reached 97.40 dB, while the best average R-squared ([Formula: see text]) in ROI-based quantitative analysis reached 0.991.</p><p><strong>Conclusions: </strong>We demonstrate the feasibility of using a weighted statistic, constructed from a multi-branch neural network, to accurately estimate the complete IF. This approach enables the generation of high-quality parametric images with shortened scan protocols, effectively reducing scanning time while ensuring accurate Patlak analysis.</p>","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"100"},"PeriodicalIF":3.2,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12698913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145699905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04DOI: 10.1186/s40658-025-00816-6
Avery B Peterson, Scott J Wilderman, Johan Blakkisrud, Ka Kit Wong, Kirk A Frey, Yuni K Dewaraja
<p><strong>Purpose: </strong>Establishing accurate methods for red marrow (RM) dosimetry is an important step toward patient-specific treatment guidance. We compared image-based dosimetry methods and investigated their role in predicting changes in blood counts following [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy (<sup>177</sup>Lu RLT).</p><p><strong>Methods: </strong>Four image-based dosimetry methodologies were applied to patients who received 2-bed position serial <sup>177</sup>Lu SPECT/CT after cycle 1 of RLT, with segmentation of all spongiosa within the field-of-view performed on CT using deep learning tools. Cycle 1 RM absorbed doses (ADs) were estimated with: 1) the time-integrated activity (TIA) in segmented spongiosa coupled with MIRD-based S-values (MIRD); 2) the TIA concentration in the segmented aorta (a surrogate for blood-based dosimetry) coupled with MIRD-based S values (MIRD<sub>aorta</sub>); 3) the voxel-level TIA map coupled with an in-house Monte Carlo (MC) dosimetry code that incorporated a micro-scale modeling of the spongiosa (MC); and 4) a novel method that utilizes [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and [<sup>99m</sup>Tc]Tc-sulfur colloid (SC) SPECT/CT for tumor and marrow localization coupled with the above MC code, modified to allow tumor infiltration of the spongiosa (MC<sub>SC+PET</sub>). Spearman rank correlation of AD from the four methods with changes in select blood counts was evaluated.</p><p><strong>Results: </strong>Imaging data was available for 20 patients for methods 1-3, while SC images were available for 12 patients for method 4. Cycle 1 AD to the FOV RM was, on average, 1.9 Gy (range: 0.1-8.0 Gy) for MIRD, 0.08 Gy (range: 0.01-0.27 Gy) for MIRD<sub>aorta</sub>, 2.5 Gy (range: 0.1-10.3 Gy) for MC, and 1.6 Gy (range: 0.1-4.6 Gy) for MC<sub>SC+PET</sub>. The ADs from MIRD<sub>aorta</sub> were not concordant with MIRD, MC, or MC<sub>SC+PET</sub> (|CCC|< 0.01) and were generally underestimates. For 3 patients with high bone tumor burden, MC<sub>SC+PET</sub> gave lower average AD than MIRD (39%) and MC (53%), potentially due to more accurate localization of marrow and tumor. Cycle 1 RM ADs were correlated with relative change in blood counts at 6-weeks post-cycle 1 with significant correlation observed for neutrophils with MIRD, MC, and MC<sub>SC+PET</sub> with Spearman rank correlations ranging from r = - 0.61 to r = - 0.88 (P < 0.01). Correlation with white blood cells at 6-months was also significant with r = - 0.80 (P < 0.01) for these three methods. MIRD<sub>aorta</sub> did not correlate with any acute or chronic changes in blood counts.</p><p><strong>Conclusion: </strong>The RM AD estimates from the blood-based surrogate were not concordant with the other image-based calculations and did not correlate with changes in blood values. Including patient-specific tumor and marrow distribution information resulted in lower AD for patients with a high bone metastatic burden. These findings have implication
{"title":"Comparison of imaging-based bone marrow dosimetry methodologies and their dose-effect relationships in [<sup>177</sup>Lu]Lu-PSMA-617 RLT including a novel method with active marrow localization.","authors":"Avery B Peterson, Scott J Wilderman, Johan Blakkisrud, Ka Kit Wong, Kirk A Frey, Yuni K Dewaraja","doi":"10.1186/s40658-025-00816-6","DOIUrl":"10.1186/s40658-025-00816-6","url":null,"abstract":"<p><strong>Purpose: </strong>Establishing accurate methods for red marrow (RM) dosimetry is an important step toward patient-specific treatment guidance. We compared image-based dosimetry methods and investigated their role in predicting changes in blood counts following [<sup>177</sup>Lu]Lu-PSMA-617 radioligand therapy (<sup>177</sup>Lu RLT).</p><p><strong>Methods: </strong>Four image-based dosimetry methodologies were applied to patients who received 2-bed position serial <sup>177</sup>Lu SPECT/CT after cycle 1 of RLT, with segmentation of all spongiosa within the field-of-view performed on CT using deep learning tools. Cycle 1 RM absorbed doses (ADs) were estimated with: 1) the time-integrated activity (TIA) in segmented spongiosa coupled with MIRD-based S-values (MIRD); 2) the TIA concentration in the segmented aorta (a surrogate for blood-based dosimetry) coupled with MIRD-based S values (MIRD<sub>aorta</sub>); 3) the voxel-level TIA map coupled with an in-house Monte Carlo (MC) dosimetry code that incorporated a micro-scale modeling of the spongiosa (MC); and 4) a novel method that utilizes [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT and [<sup>99m</sup>Tc]Tc-sulfur colloid (SC) SPECT/CT for tumor and marrow localization coupled with the above MC code, modified to allow tumor infiltration of the spongiosa (MC<sub>SC+PET</sub>). Spearman rank correlation of AD from the four methods with changes in select blood counts was evaluated.</p><p><strong>Results: </strong>Imaging data was available for 20 patients for methods 1-3, while SC images were available for 12 patients for method 4. Cycle 1 AD to the FOV RM was, on average, 1.9 Gy (range: 0.1-8.0 Gy) for MIRD, 0.08 Gy (range: 0.01-0.27 Gy) for MIRD<sub>aorta</sub>, 2.5 Gy (range: 0.1-10.3 Gy) for MC, and 1.6 Gy (range: 0.1-4.6 Gy) for MC<sub>SC+PET</sub>. The ADs from MIRD<sub>aorta</sub> were not concordant with MIRD, MC, or MC<sub>SC+PET</sub> (|CCC|< 0.01) and were generally underestimates. For 3 patients with high bone tumor burden, MC<sub>SC+PET</sub> gave lower average AD than MIRD (39%) and MC (53%), potentially due to more accurate localization of marrow and tumor. Cycle 1 RM ADs were correlated with relative change in blood counts at 6-weeks post-cycle 1 with significant correlation observed for neutrophils with MIRD, MC, and MC<sub>SC+PET</sub> with Spearman rank correlations ranging from r = - 0.61 to r = - 0.88 (P < 0.01). Correlation with white blood cells at 6-months was also significant with r = - 0.80 (P < 0.01) for these three methods. MIRD<sub>aorta</sub> did not correlate with any acute or chronic changes in blood counts.</p><p><strong>Conclusion: </strong>The RM AD estimates from the blood-based surrogate were not concordant with the other image-based calculations and did not correlate with changes in blood values. Including patient-specific tumor and marrow distribution information resulted in lower AD for patients with a high bone metastatic burden. These findings have implication","PeriodicalId":11559,"journal":{"name":"EJNMMI Physics","volume":" ","pages":"1"},"PeriodicalIF":3.2,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12779781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}